KAM MUELLER: Open Payments
NPI 1265943625 · GLENVIEW, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 46 payments from 12 companies in 2025. Trend: 2023 $343 · 2024 $108 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 20 | $516 |
| Gilead Sciences, Inc. | 6 | $255 |
| Merck Sharp & Dohme LLC | 6 | $174 |
| Theratechnologies Inc. | 3 | $63 |
| Napo Pharmaceuticals Inc | 3 | $52 |
| Braeburn Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Indivior Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
Products named: APRETUDE, CABENUVA, Biktarvy, PIFELTRO, DOVATO, EGRIFTA, Mytesi, RUKOBIA.
Industry payments across IL — which companies pay providers there.
